A potential bias in safety evaluation during open-label extensions of randomized clinical trials.

scientific article published on May 2004

A potential bias in safety evaluation during open-label extensions of randomized clinical trials. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/PDS.943
P8608Fatcat IDrelease_yikjv6gdujek5hoyzblvxbs22i
P698PubMed publication ID15133780

P50authorKenneth RothmanQ25190000
P2093author name stringKenneth J Rothman
P433issue5
P921main subjectbiasQ742736
P304page(s)295-298
P577publication date2004-05-01
P1433published inPharmacoepidemiology and Drug SafetyQ15759496
P1476titleA potential bias in safety evaluation during open-label extensions of randomized clinical trials
P478volume13

Reverse relations

cites work (P2860)
Q41677049Assessing bias: the importance of considering confounding
Q57786004Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
Q43854731Occurrence of community-acquired respiratory tract infection in patients receiving esomeprazole: retrospective analysis of adverse events in 31 clinical trials
Q42439105Safety of efalizumab therapy in patients with moderate to severe psoriasis: an open-label extension of a phase IIIb trial.

Search more.